Jone-Long Ko

A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities.

Monoclonal antibodies reactive with defined regions of the t cell antigen receptor

LAPTM5: A Novel Lysosomal-Associated Multispanning Membrane Protein Preferentially Expressed in Hematopoietic Cells ☆

Methods of inhibiting complement activation

Targeted disruption of guanosine diphosphate-dissociation inhibitor for Rho-related proteins, GDID4: normal hematopoietic differentiation but subtle defect in superoxide production by macrophages derived from in vitro embryonal stem cell differentiation

T-cell receptor variable region gene usage in T-cell populations

Soluble cd28 proteins and methods of treatment therewith

Two Distinct Immunogenic Epitopes on the α Chain of Human T Cell Antigen Receptor

Plasmid-directed synthesis of genuine adenovirus 2 early-region 1A and 1B proteins in Escherichia coli.

CHIMERIC PROTEIN WHICH BLOCKS COMPLEMENT ACTIVATION